Agonistic antibodies to costimulatory molecules, OX40 and GITR, significantly enhance the antitumor efficacy of Listeria monocytogenes (Lm-LLO)-based immunotherapy

Mikayel Mkrtichyan, Rajeev Shrimali, Rasha Abu Eid, Zuzana Berrong, Anu Wallecha, Robert Petit, Samir N Khleif, Shamim Ahmad

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationCancer Research
PublisherAmerican Association for Cancer Research Inc.
Volume75
Edition15 Supp
DOIs
Publication statusPublished - 1 Aug 2015

Publication series

NameProceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015
PublisherAmerican Association of Cancer Research
ISSN (Print)0008-5472
ISSN (Electronic)1538-7445

Cite this

Mkrtichyan, M., Shrimali, R., Abu Eid, R., Berrong, Z., Wallecha, A., Petit, R., ... Ahmad, S. (2015). Agonistic antibodies to costimulatory molecules, OX40 and GITR, significantly enhance the antitumor efficacy of Listeria monocytogenes (Lm-LLO)-based immunotherapy. In Cancer Research (15 Supp ed., Vol. 75). [LB-229] (Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015). American Association for Cancer Research Inc.. https://doi.org/10.1158/1538-7445.AM2015-LB-229